GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B6519 Xamoterol hemifumarateSummary: β1-adrenoceptor partial agonist B6519 Xamoterol hemifumarateSummary: β1-adrenoceptor partial agonist
-   B6309 Cinanserin hydrochlorideSummary: 5-HT2 antagonist B6309 Cinanserin hydrochlorideSummary: 5-HT2 antagonist
-   B6517 BRL 37344, sodium saltSummary: β3-adrenoceptor agonist,potent and selective B6517 BRL 37344, sodium saltSummary: β3-adrenoceptor agonist,potent and selective
-   B5994 Cyclobenzaprine HClSummary: 5-HT2 receptor antagonist B5994 Cyclobenzaprine HClSummary: 5-HT2 receptor antagonist
-   B6515 WB 4101 hydrochlorideSummary: α1A-adrenergic antagonist B6515 WB 4101 hydrochlorideSummary: α1A-adrenergic antagonist
-   B5717 Org 37684Summary: 5-HT2 receptors agonist B5717 Org 37684Summary: 5-HT2 receptors agonist
-   B6509 ZD 7114 hydrochlorideSummary: β3-adrenoceptor agonist B6509 ZD 7114 hydrochlorideSummary: β3-adrenoceptor agonist
-   B5688 LP 20 hydrochlorideSummary: ligand of the 5-HT7 receptor B5688 LP 20 hydrochlorideSummary: ligand of the 5-HT7 receptor
-   B6508 ARC 239 dihydrochlorideSummary: α2B adrenoceptor antagonist B6508 ARC 239 dihydrochlorideSummary: α2B adrenoceptor antagonist
-   B5687 PU 02Summary: negative allosteric modulator of 5-HT3 receptors B5687 PU 02Summary: negative allosteric modulator of 5-HT3 receptors
